↓ Skip to main content

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Overview of attention for article published in Alzheimer's Research & Therapy, October 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

news
3 news outlets
twitter
5 X users

Citations

dimensions_citation
81 Dimensions

Readers on

mendeley
172 Mendeley